Lexaria Bioscience (LEXX) Amortization - Intangibles (2021)
Lexaria Bioscience's (LEXX) quarterly Amortization - Intangibles came in at $1601.0 in Q3 2021, down 51.7% quarter-over-quarter from $3315.0 in Q2 2021.
Lexaria Bioscience (LEXX) Amortization - Intangibles (2021) Analysis & Trends
Lexaria Bioscience has disclosed Amortization - Intangibles across 1 years of filings, most recently posting $1601.0 for Q3 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - |
| 10 | Lexaria Bioscience | 7.17 Mn | 1.65 Mn | 20,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Aug 31, 2021 | 1,601.00 |
| May 31, 2021 | 3,315.00 |